Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
[<sup>99m</sup>Tc]Tc-HYNIC-iPSMA is a promising option to identify PSMA-positive prostate cancer on SPECT and could improve patient access to PSMA imaging worldwide.
Authors
- Peter Tually
- Paul Galette
- Geoffrey Michael Currie (ORCID: https://orcid.org/0000-0002-6180-8586)
- Yehia Omar (ORCID: https://orcid.org/0000-0003-3518-1377)
- Ryan Yudistiro (ORCID: https://orcid.org/0000-0003-1418-2661)
- Mike Sathekge (ORCID: https://orcid.org/0000-0002-2806-0625)
- Neel Patel (ORCID: https://orcid.org/0000-0002-8623-0936)
- G Bolland
- David Cade
- Fuad Novruzov (ORCID: https://orcid.org/0000-0002-3175-0459)
- Tracey J. Brown
- Rebecca Lo Bue
- Virginia García Quinto
Institutions
- Charles Sturt University (AU)
- Instituto Tecnológico de Cancún (MX)
- Epix Pharmaceuticals (United States) (US)
- National Nuclear Research Center (AZ)
- Siloam Eye Hospital (KR)
- University of Pretoria (ZA)
Publication Details
- Journal
- EJNMMI Reports
- Published
- 2024-12-29
- DOI
- https://doi.org/10.1186/s41824-024-00226-4
- Citations
- 6
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.51